tradingkey.logo
tradingkey.logo
Search

Foghorn Therapeutics Inc.

FHTX
Add to Watchlist
2.070USD
+0.020+0.98%
Close 11-13 16:00(ET)
122.94MMarket Cap
LossP/E TTM

Today

+0.98%

5 Days

+10.70%

1 Month

+11.89%

6 Months

-48.76%

Year to Date

-61.67%

1 Year

-55.86%

Key Figures

2.040Open
2.080High
70.02KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
2.050Prev. Close
1.950Low
141.58KTurnover
LossP/E Static
-8.69P/B
0.00%Div Yield TTM
-31.33%ROA
7.61052wk High
0.08Volume Ratio
-86.62MNet Profit
59.39MShares
-1.1656EPS TTM
2.91Beta
-470.38%ROE
1.79052wk Low
6.34%Amplitude
100.00%Gross Margin
122.94MMarket Cap
4.69Reward/Risk
5.14%Risk Rate
More news coming soon, stay tuned...

Foghorn Therapeutics Inc.'s Score

0.04vs previous score
Forecast7.80
Financial Health8.11
Technical4.51
Valuation Dimensions8.40
Institutional Confidence7.00
Risk Assessment2.46

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
5.500Target Price
+164.42%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy35555555
Buy35555555
Hold40000000
Sell00000000
Strong Sell00000000

Foghorn Therapeutics Inc. Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.80/-0.24
Revenue / Forecast
83.54M/7.10M

Foghorn Therapeutics Inc. Profile

SectorBiotechnology & Medical Research
Ticker SymbolFHTX
Number of employees112
CountryUnited States of America

Ownership

ShareholdersProportion
Flagship Ventures21.59%
Fidelity Management & Research Company LLC9.19%
BVF Partners L.P.9.03%
Eli Lilly and Company6.81%
Shareholder TypesProportion
Investment Advisor22.50%
Venture Capital21.61%
Hedge Fund17.42%
Corporation10.46%

FAQs

What is the current price of Foghorn Therapeutics Inc. (FHTX)?

The current price of Foghorn Therapeutics Inc. (FHTX) is 2.07.

What is the symbol of Foghorn Therapeutics Inc.?

The ticker symbol of Foghorn Therapeutics Inc. is FHTX.

What is the 52-week high of Foghorn Therapeutics Inc.?

The 52-week high of Foghorn Therapeutics Inc. is 7.61.

What is the 52-week low of Foghorn Therapeutics Inc.?

The 52-week low of Foghorn Therapeutics Inc. is 1.79.

What is the market capitalization of Foghorn Therapeutics Inc.?

The market capitalization of Foghorn Therapeutics Inc. is 122.94M.

Is Foghorn Therapeutics Inc. (FHTX) currently rated as Buy, Hold, or Sell?

According to analysts, Foghorn Therapeutics Inc. (FHTX) has an overall rating of Buy, with a price target of 5.50.

What is the Earnings Per Share (EPS TTM) of Foghorn Therapeutics Inc. (FHTX)?

The Earnings Per Share (EPS TTM) of Foghorn Therapeutics Inc. (FHTX) is -1.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.